← Back to Browse
ProductDiagnostic Tests

CRISPR-Based NTM Diagnostic Assay

United States

A CRISPR diagnostic assay for detecting nontuberculous mycobacteria infections with accurate pathogen identification. Supports clinical decision-making through early and reliable detection.

Manufactured by

Intelligenome

United States

IntelliGenome develops diagnostic technology for serious health challenges with a vision to create a diagnostic platform that transforms the lives of people impacted by infectious disease. The company has developed and validated ultra-sensitive CRISPR-based detection of low abundance nucleic acid in small volume blood samples.

View profile & products →

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

Top sourcing countries

1China
53 relevant products
2United States
10 relevant products
3South Korea
16 relevant products
🔒

12 more sourcing countries available

Get free access to all sourcing countries identified for this product.

See all countries →

See the full supplier coverage for this product

Get free access to all relevant manufacturers, sourcing countries, and product alternatives.

Get Free Access →

Free for medical industry professionals.

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 103 closest product alternatives

103 products

100 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products